Jemal A, Siegel R, Xu J, Ward E: Cancer Statistics, 2010. CA Cancer J Clin. 2010, 60: 277-300. 10.3322/caac.20073.
Article
PubMed
Google Scholar
Landoni F, Maneo A, Colombo A, Placa F, Milani R, Perego P, Favini G, Ferri L, Mangioni C: Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet. 1997, 350: 535-40. 10.1016/S0140-6736(97)02250-2.
Article
CAS
PubMed
Google Scholar
Disaia PJ, Creasman WT: Cervical Cancer. Clinical Gynecologic Oncology. Edited by: Disaia PJ, Creasman WT. 1997, St. Louis: Mosby Yearbook, Inc, 1-106.
Google Scholar
Papetti M, Herman IM: Mechanisms of normal and tumor-derived angiogenesis. Am J Physiol Cell Physiol. 2002, 282: C947-C970.
Article
CAS
PubMed
Google Scholar
Contrino J, Hair G, Kreutzer DL, Rickles FR: In situ detection of tissue factor in vascular endothelial cells: Correlation with the malignant phenotype of human breast disease. Nat Med. 1996, 2: 209-215. 10.1038/nm0296-209.
Article
CAS
PubMed
Google Scholar
Abe K, Shoji M, Chen J, Bierhaus A, Danave I, Micko C, Casper K, Dillehay DL, Nawroth PP, Rickles FR: Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor. Proc Natl Aca Sci USA. 1999, 96: 8663-8668. 10.1073/pnas.96.15.8663.
Article
CAS
Google Scholar
Santin AD, Hermonat PL, Ravaggi A, Pecorelli S, Cannon MJ, Parham GP: Secretion of vascular endothelial growth factor in adenocarcinoma and squamous cell carcinoma of the uterine cervix. Obstet Gynecol. 1999, 94: 78-82. 10.1016/S0029-7844(99)00282-3.
CAS
PubMed
Google Scholar
Goncharuk IV, Vorobjova LI, Lukyanova NY, Chekhun VF: Vascular endothelial growth factor exression in uterine cervical cancer: correlation with clinicopathologic characteristics and survival. Exp Oncol. 2009, 31: 179-81.
CAS
PubMed
Google Scholar
Ruf W: Tissue factor and PAR signaling in tumor progression. Thromb Res. 2007, 120: S7-S12.
Article
PubMed
Google Scholar
Hu Z, Sun Y, Garen A: Targeting tumor vasculature endothelial cells and tumor cells for immunotherapy of human melanoma in a mouse xenograft model. Proc Natl Aca Sci USA. 1999, 96: 8161-8166. 10.1073/pnas.96.14.8161.
Article
CAS
Google Scholar
Hu Z, Garen A: Intratumoral injection of adenoviral vectors encoding tumor-targeted immunoconjugates for cancer immunotherapy. Proc Natl Aca Sci USA. 2000, 97: 9221-9225. 10.1073/pnas.97.16.9221.
Article
CAS
Google Scholar
Hu Z, Garen A: Targeting tissue factor on tumor vascular endothelial cells and tumor cells for immunotherapy in mouse models of prostatic cancer. Proc Natl Aca Sci USA. 2001, 98: 12180-12185. 10.1073/pnas.201420298.
Article
CAS
Google Scholar
Waxman E, Ross JB, Laue TM, Guha A, Thiruvikraman SV, Lin TC, Konigsberg WH, Nemerson Y: Tissue factor and its extracellular soluble domain: the relationship between intermolecular association with factor VIIa and enzymatic activity of the complex. Biochemistry. 1992, 31: 3998-4003. 10.1021/bi00131a015.
Article
CAS
PubMed
Google Scholar
Presta L, Sims P, Meng YG, Moran P, Bullens S, Bunting S, Schoenfeld J, Lowe D, Lai J, Rancatore P, Iverson M, Lim A, Chisholm V, Kelley RF, Riederer M, Kirchhofer D: Generation of a humanized, high affinity anti-tissue factor antibody for use as a novel antithrombotic therapeutic. Thromb Haemost. 2001, 85: 379-389.
CAS
PubMed
Google Scholar
Dickinson CD, Kelly CR, Ruf W: Identification of surface residues mediating tissue factor binding and catalytic function of the serine protease factor VIIa. Proc Natl Acad Sci USA. 1996, 93: 14379-84. 10.1073/pnas.93.25.14379.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bellone S, El-Sahwi K, Cocco E, Casagrande F, Cargnelutti M, Palmieri M, Bignotti E, Romani C, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD: Human papillomavirus type 16 (HPV-16) virus-like particle L1-specific CD8+ cytotoxic T lymphocytes (CTLs) are equally effective as E7-specific CD8+ CTLs in killing autologous HPV-16-positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines. J Virol. 2009, 83: 6779-89. 10.1128/JVI.02443-08.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cocco E, Hu Z, Richter CE, Bellone S, Casagrande F, Bellone M, Todeschini P, Krikun G, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Buza N, Pecorelli S, Lockwood CJ, Santin AD: hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor for immunotherapy of uterine serous papillary carcinoma. Br J Cancer. 2010, 103: 812-9. 10.1038/sj.bjc.6605760.
Article
CAS
PubMed
PubMed Central
Google Scholar
Alessi P, Ebbinghaus C, Neri D: Molecular targeting of angiogenesis. Biochim Biophys Acta. 2004, 4: 39-49.
Google Scholar
Veras E, Srodon M, Neijstrom ES, Ronnett BM: Metastatic HPV-related cervical adenocarcinomas presenting with thromboembolic events (Trousseau Syndrome): clinicopathologic characteristics of 2 cases. Int J Gynecol Pathol. 2009, 28: 134-9. 10.1097/PGP.0b013e318186a83b.
Article
PubMed
Google Scholar
Simon NL, Orr JW, Hatch KD, et al: Lower extremity edema due to deep vein thrombosis in patients with recurrent cervix cancer. Gynecol Oncol. 1984, 19: 30-3. 10.1016/0090-8258(84)90154-9.
Article
CAS
PubMed
Google Scholar
Mohammed S, Khodadoust K: Carcinoma of the cervix causing massive intracardiac embolus. Gynecol Oncol. 1995, 56: 294-7. 10.1006/gyno.1995.1049.
Article
CAS
PubMed
Google Scholar
Barbera L, Thomas G: Venous thromboembolism in cervical cancer. Lancet Oncol. 2008, 9: 54-60. 10.1016/S1470-2045(07)70409-6.
Article
PubMed
Google Scholar
Satoh T, Oki A, Uno K, Sakurai M, Ochi H, Okada S, Minami R, Matsumoto K, Tanaka YO, Tsunoda H, Homma S, Yoshikawa H: High incidence of silent venous thromboembolism before treatment in ovarian cancer. Br J Cancer. 2007, 97: 1053-7. 10.1038/sj.bjc.6603989.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rak J, Milsom C, May L, Klement P, Yu J: Tissue factor in cancer and angiogenesis: the molecular link between genetic tumor progression, tumor neovascularization, and cancer coagulopathy. Semin Thromb Hemost. 2006, 32: 54-70. 10.1055/s-2006-933341.
Article
CAS
PubMed
Google Scholar
Mueller BM, Reisfeld RA, Edgington TS, Ruf W: Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. Proc Natl Acad Sci USA. 1992, 89: 11832-11836. 10.1073/pnas.89.24.11832.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yu JL, May L, Lhotak V, Shahrzad S, Shirasawa S, Weitz JI, Coomber BL, Mackman N, Rak JW: Oncogenic events regulate tissue factor expression in colorectal cancer cells: Implications for tumor progression and angiogenesis. Blood. 2005, 105: 1734-1741. 10.1182/blood-2004-05-2042.
Article
CAS
PubMed
Google Scholar
Monk BJ, Willmott LJ, Sumner DA: Anti-angiogenesis agents in metastatic or recurrent cervical cancer. Gynecol Oncol. 2010, 116: 181-6. 10.1016/j.ygyno.2009.09.033.
Article
CAS
PubMed
Google Scholar
Ortaldo JR, Woodhouse CS, Morgan AC, Herberman RB, Cheresh DA, Reisfeld RA: Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies. J Immunol. 1987, 138: 3566-3572.
CAS
PubMed
Google Scholar
Clynes RA, Towers TL, Presta LG, Ravetch JV: Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets. Nature Med. 2000, 6: 443-446. 10.1038/74704.
Article
CAS
PubMed
Google Scholar
Fehniger TA, Bluman EM, Porter MM, Mrozek E, Cooper MA, VanDeusen JB, Frankel SR, Stock W, Caligiuri MA: Potential mechanisms of human natural killer cell expansion in vivo during low-dose IL-2 therapy. J Clin Invest. 2000, 106: 117-124. 10.1172/JCI6218.
Article
CAS
PubMed
PubMed Central
Google Scholar
Caron PC, Lai LT, Scheinberg DA: Interleukin-2 enhancement of cytotoxicity by humanized monoclonal antibody M195 (anti-CD33) in myelogenous leukemia. Clin Cancer Res. 1995, 1: 63-70.
CAS
PubMed
Google Scholar
Santin AD, Bellone S, Palmieri M, Ravaggi A, Romani C, Tassi R, Roman JJ, Burnett A, Pecorelli S, Cannon MJ: HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities. Gynecol Oncol. 2006, 100: 469-78. 10.1016/j.ygyno.2005.09.040.
Article
CAS
PubMed
Google Scholar
Fiander A, Adams M, Evans AS, Bennett AJ, Borysiewicz LK: Immunocompetent for immunotherapy? A study of the immunocompetence of cervical cancer patients. Int J Gynecol Oncol. 1995, 5: 438-42. 10.1046/j.1525-1438.1995.05060438.x.
Article
Google Scholar
Santin AD, Hermonat PL, Ravaggi A, Bellone S, Roman J, Pecorelli S, et al: Effects of concurrent cisplatinum administration during radiotherapy vs. radiotherapy alone on the immune function of patients with cancer of the uterine cervix. Int J Radiat Oncol Biol Phys. 2000, 48: 997-1006. 10.1016/S0360-3016(00)00769-0.
Article
CAS
PubMed
Google Scholar
Santin AD, Bellone S, Palmieri M, Bossini B, Dunn D, Roman JJ, et al: Effect of blood transfusion during radiotherapy on the immune function of patients with cancer of the uterine cervix: role of interleukin-10. Int J Radiat Oncol Biol Phys. 2002, 54: 1345-55. 10.1016/S0360-3016(02)03757-4.
Article
CAS
PubMed
Google Scholar